ezetimibe has been researched along with raltegravir potassium in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (raltegravir potassium) | Trials (raltegravir potassium) | Recent Studies (post-2010) (raltegravir potassium) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 1,238 | 243 | 879 |
| Protein | Taxonomy | ezetimibe (IC50) | raltegravir potassium (IC50) |
|---|---|---|---|
| Translocator protein | Rattus norvegicus (Norway rat) | 0.13 | |
| Integrase | Human immunodeficiency virus 1 | 0.0494 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armenis, K; Back, D; Boffito, M; Bonora, S; D'Avolio, A; Gazzard, B; Jackson, A; Moyle, G; Taylor, J; Watson, V | 1 |
1 trial(s) available for ezetimibe and raltegravir potassium
| Article | Year |
|---|---|
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.
Topics: Adult; Anticholesteremic Agents; Antiviral Agents; Azetidines; Cross-Over Studies; Drug Therapy, Combination; Ezetimibe; Female; Healthy Volunteers; Humans; Male; Middle Aged; Prospective Studies; Pyrrolidinones; Raltegravir Potassium | 2011 |